Both in Pharmaceuticals
Rein Therapeutics vs Nomad Power Solutions
Over the past year RNTX returned −9.0% and NMAD returned +13.8%; their daily moves had a correlation of 0.20.
RNTX −9.0% NMAD +13.8%Growth of $1, one year, split-adjusted
| Metric | RNTX | NMAD |
|---|---|---|
| Price | $0.7147 | $4.03 |
| Market cap | $61.7M | $64.9M |
| Today | +1.49% | +2.28% |
| 1 month | −9.5% | +7.5% |
| 6 months | −43.9% | — |
| Year to date | −38.4% | — |
| 1 year | −47.1% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $40.6M | — |
| Dividend yield | — | — |
| Volatility (60d) | 97.0% | — |
| Short % of float | 2.6% | 11.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).